(Press-News.org) Contact information: Catherine Kolf
ckolf@jhmi.edu
443-287-2251
Johns Hopkins Medicine
Potential for added medical benefits uncovered for widely used breast cancer drug
Lab tests show it protects cells from UV radiation, inflammation and oxidative damage
Exemestane, a synthetic steroid drug widely prescribed to fight breast cancers that thrive on estrogens, not only inhibits the production of the hormone, but also appears to protect cells throughout the body against damage induced by UV radiation, inflammation and other assaults, according to results of research by Johns Hopkins scientists.
A summary of the research, performed on a variety of different animal and human cells, was published online in the Proceedings of the National Academy of Sciences on Nov. 4, and suggests that exemestane's effectiveness against breast cancer could be due to more than its ability to halt estrogen production, the scientists say. The study's results further imply that the drug, a so-called aromatase (estrogen synthesis) inhibitor, could potentially be prescribed more widely, including to men, as a way to counteract the wear and tear on cells that often leads to chronic diseases.
"Cells already have their own elaborate protective mechanisms, and in many cases they are 'idling.' The right drugs and foods can turn them on to full capacity," says Paul Talalay, M.D., the John Jacob Abel Distinguished Service Professor of Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine. "In our cell studies, we found that exemestane does exactly that," he adds.
Talalay explains that cells are constantly under assault from a wide range of potentially lethal agents. UV radiation from the sun can cause errors in DNA sequences; reactive oxygen species — a class of unstable, oxygen-containing chemicals that are a natural byproduct of cellular functioning — can build up and cause damage to DNA and proteins; and ongoing inflammation can damage many essential cell functions.
To withstand the pressures against them, cells have evolved various mechanisms for protecting themselves. One involves turning on genes that produce a "SWAT team" of proteins, he notes, collectively called the phase 2 response. In normal cells, this response is not fully active. In previous work, the Talalay group found that sulforaphane, a chemical found in broccoli and other vegetables, can ramp up the phase 2 response and help protect cells from the constant wear and tear that they experience.
"Looking at the chemical structure of exemestane, I realized that it was similar to sulforaphane, and I wondered if it too could boost cells' phase 2 protective responses," says Talalay.
To demonstrate that exemestane revs up the phase 2 response, Hua Liu, a research associate in Talalay's laboratory, tested exemestane's effects on various types of cells, including liver tumor and skin cells from a mouse, human cells from the eye's retina, and rat heart cells. As expected, the addition of exemestane elevated the activity of typical protective phase 2 response enzymes in all of the cells tested, a result similar to the effects of adding sulforaphane.
Exemestane was also effective in reducing the amount of reactive oxygen species in human retinal cells, where they are thought to contribute to age-related macular degeneration. It was also able to protect rat heart cells from similar damage.
To test the drug's ability to protect skin cells from UV-induced damage, Liu treated mouse skin cells with exemestane a day before subjecting them to UV radiation and, again, exemestane was able to protect the cells significantly, Liu and Talalay say.
Assessing exemestane's ability to protect cells from inflammation produced a surprise, Talalay notes. In all the other tests, Liu and Talalay had tried not only exemestane but also a mixture of exemestane and sulforaphane. They generally found that the two had an additive effect, suggesting that they both worked in a similar way and were more or less interchangeable. However, when mouse immune cells were exposed to both exemestane and sulforaphane, the two together were much more potent and at lower doses than either chemical alone.
"Our research showed unexpectedly that exemestane has multiple actions, which suggests that a wider use of exemestane should be considered if clinical tests confirm our cellular studies," says Talalay. "Of course, even if clinical tests confirm what we saw in cells, exemestane may not be appropriate for everyone. It's already advocated as a preventive measure for high-risk breast cancer populations, but it may also be valuable in preventing other noncancerous chronic diseases."
Talalay notes that the drug is already approved by the U.S. Food and Drug Administration and taken by tens of thousands of women, with minimal side effects.
###
This work was supported by grants from the Lewis B. and Dorothy Cullman Foundation and from Murakami Noen.
On the Web:
Link to article: http://dx.doi.org/10.1073/pnas.1318247110
Talalay Lab: http://www.hopkinsmedicine.org/pharmacology_molecular_sciences/faculty/bios/talalay.html
Media Contacts: Catherine Kolf; 443-287-2251; ckolf@jhmi.edu
Vanessa McMains; 410-502-9410; vmcmain1@jhmi.edu
Shawna Williams; 410-955-8236; shawna@jhmi.edu END
Potential for added medical benefits uncovered for widely used breast cancer drug
Lab tests show it protects cells from UV radiation, inflammation and oxidative damage
2013-11-07
ELSE PRESS RELEASES FROM THIS DATE:
'Diabetic flies' can speed up disease-fighting research
2013-11-07
'Diabetic flies' can speed up disease-fighting research
Fruit flies make good stand-ins for humans in diabetes treatment tests, UMD study finds
COLLEGE PARK, Md - In a finding that has the potential to significantly speed up diabetes research, scientists at the University ...
Children who have autism far more likely to have tummy troubles
2013-11-07
Children who have autism far more likely to have tummy troubles
The gastrointestinal problems are linked to problem behaviors in children with autism, developmental delay
Children with autism experience gastrointestinal (GI) ...
Speaking a second language may delay different dementias
2013-11-07
Speaking a second language may delay different dementias
MINNEAPOLIS – In the largest study on the topic to date, research shows that speaking a second language may delay the onset of three types of dementias. The research is published in the November 6, 2013, ...
Floods didn't provide nitrogen 'fix' for earliest crops in frigid North
2013-11-07
Floods didn't provide nitrogen 'fix' for earliest crops in frigid North
Floods didn't make floodplains fertile during the dawn of human agriculture in the Earth's far north because the waters were virtually devoid of nitrogen, unlike other areas of the globe scientists ...
Monkeys use minds to move 2 virtual arms
2013-11-07
Monkeys use minds to move 2 virtual arms
DURHAM, N.C. – In a study led by Duke researchers, monkeys have learned to control the movement of both arms on an avatar using just their brain activity.
The findings, published Nov. 6, 2013, in the ...
X-rays reveal inner structure of the Earth's ancient magma ocean
2013-11-07
X-rays reveal inner structure of the Earth's ancient magma ocean
First look into molten basalt at deep mantle conditions
This news release is available in German.
Using the world's most brilliant X-ray source, scientists have for the first ...
Stress makes snails forgetful
2013-11-07
Stress makes snails forgetful
Snail study reveals that stress is bad for memory
New research on pond snails has revealed that high levels of stress can block memory processes. Researchers from the University of Exeter and the University of Calgary trained snails ...
Annual car crash deaths in England and Wales have fallen 40 percent in 50 years
2013-11-07
Annual car crash deaths in England and Wales have fallen 40 percent in 50 years
But may still contribute to social class and gender differences in life expectancy
The annual number of car crash deaths in England and Wales has plunged by 41% over the past ...
Crime associated with higher mortality rates
2013-11-07
Crime associated with higher mortality rates
The new study, published in the journal PLOS ONE shows that people with drug-related criminal records in Norway have a mortality rate that can be up to 15 times higher than people ...
Discovery of HIV 'invisibility cloak' reveals new treatment opportunities
2013-11-07
Discovery of HIV 'invisibility cloak' reveals new treatment opportunities
Scientists have discovered a molecular invisibility cloak that enables HIV, the virus that causes AIDS, to hide inside cells of the body without triggering the body's natural defence systems. ...
LAST 30 PRESS RELEASES:
New “bone-digesting” cell type discovered in pythons
New study points to Skagerrak as nursery area for the enigmatic Greenland shark
Are sewage spills and coastal winds contributing to airborne microplastics?
Which factors affect the success of popular prescription weight loss drugs in individuals?
Do renter protection policies reduce rental housing discrimination?
Does grading students at earlier ages increase the risk of mental disorders in adolescents?
New artificial intelligence–based test detects early signs of osteoporosis from X-ray images
Can eating a healthy plant-based diet help protect against inflammatory bowel disease?
Do local voting rights affect migrants’ participation in protests?
Mysterious ‘Dark Dwarfs’ may be hiding at the heart of the Milky Way
Real-world data shows teclistamab can benefit many multiple myeloma patients who would have been ineligible for pivotal trial
Scientists reveal how a key inflammatory molecule triggers esophageal muscle contraction
Duration of heat waves accelerating faster than global warming
New mathematical insights into Lagrangian turbulence
Clinical trials reveal promising alternatives to high-toxicity tuberculosis drug
Artificial solar eclipses in space could shed light on Sun
Probing the cosmic Dark Ages from the far side of the Moon
UK hopes to bolster space weather forecasts with Europe's first solar storm monitor
Can one video change a teen's mindset? New study says yes - but there’s a catch
How lakes connect to groundwater critical for resilience to climate change, research finds
Youngest basaltic lunar meteorite fills nearly one billion-year gap in Moon’s volcanic history
Cal Poly Chemistry professor among three U.S. faculty to be honored for contributions to chemistry instruction
Stoichiometric crystal shows promise in quantum memory
Study sheds light on why some prostate tumors are resistant to treatment
Tree pollen reveals 150,000 years of monsoon history—and a warning for Australia’s northern rainfall
Best skin care ingredients revealed in thorough, national review
MicroRNA is awarded an Impact Factor Ranking for 2024
From COVID to cancer, new at-home test spots disease with startling accuracy
Now accepting submissions: Special Collection on Cognitive Aging
Young adult literature is not as young as it used to be
[Press-News.org] Potential for added medical benefits uncovered for widely used breast cancer drugLab tests show it protects cells from UV radiation, inflammation and oxidative damage